Refine
Year of publication
Has Fulltext
- yes (30)
Is part of the Bibliography
- no (30)
Keywords
- USP28 (3)
- proteomics (3)
- COVID-19 (2)
- Cancer (2)
- Proteomics (2)
- SARS-CoV-2 (2)
- TMT (2)
- autophagy (2)
- c-MYC (2)
- integrated stress response (2)
- lung cancer (2)
- mTOR (2)
- proteostasis (2)
- stress response (2)
- 2019-nCoV (1)
- 3′UTR length (1)
- AAA+ disaggregase (1)
- APA (1)
- ATM (1)
- Autoimmune vasculopathy (1)
- BAG3 (1)
- BRAF (1)
- Browsertool (1)
- Buparlisib (1)
- CFIm (1)
- CRISPR/Cas9 (1)
- Cas9 inhibitor (1)
- Cell Biology (1)
- Cell biology (1)
- Covid-19 (1)
- DNA-PK (1)
- Data Analysis (1)
- Degradation (1)
- Devic disease (1)
- Devic syndrome (1)
- EGFR (1)
- FIP1 (1)
- HRAS 28 Gefitinib (1)
- IR (1)
- IRF-3 (1)
- ISR (1)
- Innate immunity (1)
- Interferon (1)
- MACE-seq (1)
- MYC (1)
- Microbiology, Virology & Host Pathogen Interaction (1)
- Mitochondrial dysfunction (1)
- NF-kB (1)
- NMO-IgG (1)
- NOTCH (1)
- NSCLC (1)
- Neuromyelitis optica (1)
- Omicron (1)
- PI3K (1)
- PIK3CA (1)
- PROTAC (1)
- PTEN (1)
- Parkin (1)
- Perrault syndrome (1)
- Protein-translocation (1)
- Python (1)
- Rab7 (1)
- Radiotherapy (1)
- Research article (1)
- SILAC (1)
- SRSF3 (1)
- SRSF7 (1)
- Software (1)
- Stroke genetics (1)
- Systems & Computational Biology (1)
- Translation (1)
- Translation proteomics (1)
- Ubiquitin ligase (1)
- Vemurafenib (1)
- adipose-derived stromal/stem cells (1)
- antiviral (1)
- aprotinin (1)
- aquaporin-4 (AQP4) antibody (1)
- bioinformatics (1)
- buparlisib (1)
- c-JUN (1)
- calcitriol (1)
- cap-dependent translation (1)
- cell biology (1)
- cerebrospinal fluid (1)
- chemical-induced proximity (1)
- clinical features (1)
- coagulation (1)
- coagulopathy (1)
- dPAS (1)
- data analysis (1)
- differential expression (1)
- drug discovery (1)
- epidemiology (1)
- extracellular vesicles (1)
- gefitinib (1)
- genome editing (1)
- glioblastoma (1)
- glioblastoma stem-like cells (1)
- human (1)
- hypoxia (1)
- iCLIP (1)
- interactome (1)
- longitudinally extensive transverse myelitis (1)
- magnetic resonance imaging (1)
- mesenchymal stromal/stem cells (1)
- mitochondria (1)
- pPAS (1)
- protein quality control (1)
- pulse labeling (1)
- pulsed SILAC (1)
- recurrent optic neuritis (1)
- renal tubular epithelial cells (1)
- severe acute respiratory syndrome coronavirus (1)
- severe acute respiratory syndrome coronavirus 2 (1)
- squamous cell carcinoma (1)
- statistics (1)
- stress (1)
- thrombosis (1)
- transferrin (1)
- translation (1)
- translatome (1)
- ubiquitin (1)
- unfolded protein response (1)
- vemurafenib (1)
- vitamin D3 (1)
- ΔNp63 (1)
- π-clamp (1)
Institute
Cell-free therapy using extracellular vesicles (EVs) from adipose-derived mesenchymal stromal/stem cells (ASCs) seems to be a safe and effective therapeutic option to support tissue and organ regeneration. The application of EVs requires particles with a maximum regenerative capability and hypoxic culture conditions as an in vitro preconditioning regimen has been shown to alter the molecular composition of released EVs. Nevertheless, the EV cargo after hypoxic preconditioning has not yet been comprehensively examined. The aim of the present study was the characterization of EVs from hypoxic preconditioned ASCs. We investigated the EV proteome and their effects on renal tubular epithelial cells in vitro. While no effect of hypoxia was observed on the number of released EVs and their protein content, the cargo of the proteins was altered. Proteomic analysis showed 41 increased or decreased proteins, 11 in a statistically significant manner. Furthermore, the uptake of EVs in epithelial cells and a positive effect on oxidative stress in vitro were observed. In conclusion, culture of ASCs under hypoxic conditions was demonstrated to be a promising in vitro preconditioning regimen, which alters the protein cargo and increases the anti-oxidative potential of EVs. These properties may provide new potential therapeutic options for regenerative medicine.